Feedback / Questions
bexobrutideg (NX-5948) - Nurix Therap
https://www.globenewswire.com/news-release/2025/12/08/3201481/0/en/Nurix-Therapeutics-Presents-New-Data-from-the-Phase-1-Trial-of-Bexobrutideg-NX-5948-in-Waldenstr%C3%B6m-Macroglobulinemia-at-the-67th-American-Society-of-Hematology-ASH-Annual-Meeting-a.html
Dec 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next